Impact of Early Reinitiation of Neuropsychiatric Medications on Agitation and Delirium in the Intensive Care Unit: A Retrospective Study.
Michaelia D CucciBrittany S CunninghamJaimini S PatelAlan T ShimerDania I MoflehChanda L MullenPublished in: The Annals of pharmacotherapy (2020)
After adjustment for baseline differences, there was no difference in agitation or delirium. Independent risk factors were restraint use and newly initiated BZDs.